BioPacific Conference 2014 Agenda
Theme: Innovation through collaboration and partnership
Saturday, June 14, 2014, Crown Plaza Hotel, Foster City, CA, USA
8:00 am | Registration and Vendor Exhibition |
9:00 am | Welcome Remarks Alan Hao, PhD, CABS President-elect & 2014 BioPacific Conference Organizing Committee Chair |
9:05 am | State of the Society Zhonghua Pei, PhD, CABS President |
Session I: Success Stories and Case Studies of Innovative New Medicines Session chairpersons: Charlene Liao, Jianlong Lou & Yang Tian |
|
9:15 am | Genentech Portfolio and Collaborations Ann Lee-Karlon, PhD, SVP of Genentech |
9:45 am | “ISPY-2” Clinical Trials Hope S. Rugo, MD, Professor of Medicine at UCSF |
10:15 am | The Story of Sofosbuvir and the Race to Cure HCV William Lee, PhD, SVP of Gilead |
10:45 am | Break, Vendor Exhibition & Networking |
11:05 am | CABS K. Fong Award in Life Sciences Session chairperson: Zhonghua Pei Award Winners: Drs. Ge Li & Hing L. Sham |
11:10 am | Award Winner Speech |
Session II: Drug Discovery Research & Development through Collaboration Session chairpersons: Jiangwen Majeti & Jianlong Lou |
|
11:30 pm | Lessons from Silicon Valley Stephanie Marrus, MBA, Director of Entrepreneurship Center at UCSF |
12:00 am | Convergence in Healthcare Lee Babiss, PhD, CSO & EVP PPD Discovery Innovation, CEO X-Rx Discovery Inc |
12:30 pm | Lunch |
Session III: Diagnostics, Medical Devices and Life Science Investment Session chairpersons: Janet Xiao & Wentao Zhang |
|
1:20 pm | Next Generation Tools for Studying the Genomics in Cancer Gary Schroth, PhD, Distinguished Scientist of Illumina |
1:45 pm | Biomedical Device Design through Computational Modeling, Bench Testing, and Preclinical Models Chad Abunassar, Staff R&D Engineer, Abbott Vascular |
2:10 pm | Bridging China-US: Life Science Investments and Strategic Partnerships Frank Yu, Co-founder and CEO of Ally Bridge & Themes Investment |
2:35 pm | Patent Owners: Don’t Get Caught in the Tsunami: AIA Post-Grant Proceedings Thomas L. Irving, Partner, Finnegan |
2:55 pm | Gold Sponsor Presentations Kelly Tan, Contact Singapore, Area Director, North America Chunlin Chen, CEO, Shanghai Medicilon Jeffrey Hung, VP of Service Marketing, GenScript |
3:15 pm | Break: Vendor Exhibition & Networking |
Session IV: Drug Research & Development Trend in China Session chairpersons: Connie Sun & Zhenhai Shen |
|
3:45 pm | Pharmaceutical R&D in China: Where Shall We Go from Here? Dayao Zhao, PhD, Vice President, J & J China R&D and Scientific Affairs |
4:10 pm | The New Trends in Global Clinical Development & the Status in China Joan Shen, PhD, VP of Jiangsu Hengrui Pharma |
4:35 pm | Gold Sponsor Presentations Connie Sun, SVP of Business and Corporate Development, Pharmaron Caroline Lee, Director, Drug Transporter Sciences, QPS Charles Huang, VP of Global BD, Sundia Craig Coburn, VP, Medicinal Chemistry, International Discovery Unit, WuXi AppTec |
5:05 pm | Hangzhou HEDA: Recruiting Talents and Projects Chenpeng Yao, President and CEO, HEDA Asset Management |
5:30 pm | Dinner |
6:30 pm | Session V: Panel Discussion: Returnees’ Work Experience in China Panelist: Chunlin Chen, PhD, CEO, Medicilon Wayne Li, PhD, GM, Kunming Biomed International & Harmonia Biotechnology, Investing Director, Morningside Technologiesn Henry Lu, PhD, VP & Head of Biology, Wuxi Apptec Qiang Lu, PhD, CSO, Yangtze River Pharma Joan Shen, MD, PhD, CMO & VP, Hengrui Medicine Yingfei Wei, PhD, CEO of Elixirin, former CSO, 3S Bio Inc Dayao Zhao, MD PhD, VP, China R&D and Scientific Affairs |
8:30 pm | Conference Adjourned |